Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Abrahamsen IW"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ailawadhi S; Mayo Clinic, Jacksonville, Florida, United States., Arnulf B; Saint-Louis University Hospital AP-HP, Paris France., paris, France., Patel KK; The University of Texas, MD Anderson Cancer Center, Houston, Texas, United States., Cavo M; Seràgnoli Institute of Hematology; Bologna University School of Medicine, Bologna, Italy, Bologna, Italy., Nooka AK; Emory University Winship Cancer Institute, Atlanta, Georgia, United States., Manier S; CHU Lille, Lille, France., Callander NS; University of Wisconsin, Madison, Wisconsin, United States., Costa LJ; University of Alabama at Birmingham, Vestavia Hills, Alabama, United States., Vij R; Washington University School of Medicine, St Louis, Missouri, United States., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France., Solomon SR; Northside Hospital Cancer Institute, Atlanta, Georgia, United States., Abrahamsen IW; Oslo University Hospital, Oslo, Norway., Baz RC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States., Broijl A; Erasmus MC Cancer Institute, Rotterdam, Netherlands., Chen C; Princess Margaret Cancer Centre, Toronto., Canada., Jagannath S; Mt. Sinai Medical Center, New York, New York, United States., Raje N; Massachusetts General Hospital, Boston, Massachusetts, United States., Scheid C; University of Cologne, Cologne, Germany., Delforge M; University of Leuven, Leuven, Belgium., Benjamin R; King's College Hospital, London, United Kingdom., Pabst T; University Hospital, Inselspital, Bern, Switzerland., Iida S; Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan., Berdeja JG; Tennessee Oncology, nashville, Tennessee, United States., Giralt SA; Memorial Sloan Kettering Cancer Center, New York, New York, United States., Truppel-Hartmann A; 2seventy bio, Cambridge, Massachusetts, United States., Chen Y; Bristol Myers Squibb, Princeton, New Jersey, United States., Zhong X; Bristol Myers Squibb, Princeton, New Jersey, United States., Wu F; Bristol Myers Squibb, Princeton, New Jersey, United States., Piasecki J; Bristol Myers Squibb, Princeton, New Jersey, United States., Eliason L; Bristol Myers Squibb, Princeton, New Jersey, United States., Dhanda DS; Bristol Myers Squibb, Princeton, New Jersey, United States., Felten J; Bristol Myers Squibb, Boudry, Switzerland., Caia A; Bristol Myers Squibb, Boudry, Switzerland., Cook M; Bristol Myers Squibb, Boudry, Switzerland., Popa-Mckiver M; Bristol-Myers Squibb, Lawrenceville, New Jersey, United States., Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.
Publikováno v:
Blood [Blood] 2024 Aug 28. Date of Electronic Publication: 2024 Aug 28.
Autor:
Grønvold BL; Department of Haematology Oslo University Hospital Oslo Norway.; Institute of Clinical Medicine University of Oslo Oslo Norway., Ali MM; Department of Haematology Oslo University Hospital Oslo Norway., Myklebust TÅ; Department of Registration Cancer Registry Norway Oslo Norway.; Department of Research and Innovation Møre and Romsdal Hospital Trust Ålesund Norway., Lenartova A; Department of Haematology Oslo University Hospital Oslo Norway., Remberger M; Department of Haematology Oslo University Hospital Oslo Norway.; Department of Medical Sciences Uppsala University and KFUE Uppsala University Hospital Uppsala Sweden., Abrahamsen IW; Department of Haematology Oslo University Hospital Oslo Norway., Tjønnfjord GE; Department of Haematology Oslo University Hospital Oslo Norway.; Institute of Clinical Medicine University of Oslo Oslo Norway., Myhre AE; Department of Haematology Oslo University Hospital Oslo Norway., Fløisand Y; Center for Cancer Cell Reprogramming Institute of Clinical Medicine University of Oslo Oslo Norway., Gedde-Dahl T; Department of Haematology Oslo University Hospital Oslo Norway.; Institute of Clinical Medicine University of Oslo Oslo Norway.
Publikováno v:
EJHaem [EJHaem] 2024 Feb 05; Vol. 5 (1), pp. 117-124. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Autor:
Vo CD; Avdeling for blodsykdommer, Oslo universitetssykehus., Myhre AE; Avdeling for blodsykdommer, Oslo universitetssykehus., Abrahamsen IW; Avdeling for blodsykdommer, Oslo universitetssykehus., Remberger M; Avdeling for blodsykdommer, Oslo universitetssykehus, og, Institutionen för medicinska vetenskaper, Uppsala universitet, og, Kliniska forsknings- och utvecklingsenheten, Akademiska sjukhuset, Uppsala., Mattsson J; Section of Medical Oncology and Hematology, Department of Medicine, University of Toronto, og, Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto., Fløisand Y; Avdeling for molekylær cellebiologi, Institutt for kreftforskning, og, The Clatterbridge Cancer Centre, NHS Foundation Trust, Liverpool., Grønvold BCL; Avdeling for blodsykdommer, Oslo universitetssykehus, og, Institutt for klinisk medisin, Universitetet i Oslo., Tjønnfjord GE; Avdeling for blodsykdommer, Oslo universitetssykehus, og, Institutt for klinisk medisin, Universitetet i Oslo., Tvedt THA; Avdeling for blodsykdommer, Oslo universitetssykehus., Gedde-Dahl T; Seksjon for allogen stamcelletransplantasjon, Oslo universitetssykehus.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2023 Mar 13; Vol. 143 (4). Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
Autor:
Rørvik SD; Hjerteavdelingen, Haukeland universitetssjukehus., Abrahamsen IW; Avdeling for blodsykdommer, Oslo universitetssykehus., Myhre AE; Avdeling for blodsykdommer, Oslo universitetssykehus., Vo CD; Avdeling for blodsykdommer, Oslo universitetssykehus., Ødegaard EM; Øyeavdelingen, Oslo universitetssykehus, Ullevål sykehus., Bruserud Ø; Seksjon for blodsykdommer, Medisinsk klinikk, Haukeland universitetssjukehus, og, Universitetet i Bergen., Gedde-Dahl T; Avdeling for blodsykdommer, Oslo universitetssykehus, og, Universitetet i Oslo., Tvedt THA; Avdeling for blodsykdommer, Oslo universitetssykehus.
Publikováno v:
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2023 Mar 13; Vol. 143 (4). Date of Electronic Publication: 2023 Mar 13 (Print Publication: 2023).
Autor:
Lindahl JP; Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Barlinn R; Department of Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Abrahamsen IW; Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Spetalen S; Department of Pathology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway., Midtvedt K; Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway., Jenssen T; Department of Transplantation Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Frontiers in medicine [Front Med (Lausanne)] 2022 Mar 16; Vol. 9, pp. 849783. Date of Electronic Publication: 2022 Mar 16 (Print Publication: 2022).
Autor:
Ali MM; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: uxalmf@ous-hf.no., Grønvold B; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway., Remberger M; Department of Haematology, Oslo University Hospital, Oslo, Norway; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden., Abrahamsen IW; Department of Haematology, Oslo University Hospital, Oslo, Norway., Myhre AE; Department of Haematology, Oslo University Hospital, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway., Fløisand Y; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, University of Oslo, Oslo, Norway; The Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom., Gedde-Dahl T; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Norway.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2021 Sep; Vol. 21 (9), pp. 598-605. Date of Electronic Publication: 2021 May 11.
Autor:
Remberger M; Department of Haematology, Oslo University Hospital, Oslo, Norway; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden. Electronic address: yfloisan@ous-hf.no., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Abrahamsen IW; Department of Haematology, Oslo University Hospital, Oslo, Norway., Ali M; Department of Haematology, Oslo University Hospital, Oslo, Norway., Myhre AE; Department of Haematology, Oslo University Hospital, Oslo, Norway., Gedde-Dahl T; Department of Haematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Fløisand Y; Department of Haematology, Oslo University Hospital, Oslo, Norway; CanCell-Centre of Cancer Cell Reprogramming, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Jul; Vol. 27 (7), pp. 621.e1-621.e3. Date of Electronic Publication: 2021 Mar 24.
Autor:
Grønvold B; Department of Haematology, Oslo University Hospital, Oslo, Norway. bjoegr@ous-hf.no., Ali MM; Department of Haematology, Oslo University Hospital, Oslo, Norway., Remberger M; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden., Mattsson J; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Egeland T; Institute of Immunology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lundin KU; Institute of Immunology, Oslo University Hospital, Oslo, Norway., Myhre AE; Department of Haematology, Oslo University Hospital, Oslo, Norway., Abrahamsen IW; Department of Haematology, Oslo University Hospital, Oslo, Norway., Heldal D; Department of Haematology, Oslo University Hospital, Oslo, Norway., Dybedal I; Department of Haematology, Oslo University Hospital, Oslo, Norway., Tjønnfjord GE; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Fløisand Y; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Department of Molecular Cell Biology, Oslo University Hospital, Oslo, Norway., Gedde-Dahl T; Department of Haematology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2020 Aug; Vol. 55 (8), pp. 1658-1661. Date of Electronic Publication: 2020 Feb 13.
Autor:
Abrahamsen IW; Institute of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway., Kjellevoll S, Greve-Isdahl M, Mensali N, Wälchli S, Kumari S, Loland BF, Egeland T, Kolstad A, Olweus J
Publikováno v:
International journal of cancer [Int J Cancer] 2012 Apr 15; Vol. 130 (8), pp. 1821-32. Date of Electronic Publication: 2011 Aug 12.